XML 55 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Business acquisition (Tables)
12 Months Ended
Sep. 30, 2021
Business acquisition  
Schedule of preliminary fair value amounts of the assets acquired and liabilities assumed

The following table summarizes the preliminary fair value amounts of the assets acquired and liabilities assumed as of the acquisition date, as well as the purchase consideration:

(in thousands)

    

June 14, 2021

Assets acquired

Cash and cash equivalents

$

7

Accounts receivable

 

37

Inventories

 

14

Intangible assets

 

18,410

Goodwill

 

21,538

Liabilities assumed

Accounts payable

 

57

Accrued expenses

 

44

Deferred tax liability

 

2,252

Fair value of assets acquired and liabilities assumed

$

37,653

Consideration transferred

Cash

$

490

Company common stock

 

26,772

Contingent consideration

 

5,467

Indemnity holdback

 

4,924

Fair value of purchase consideration

$

37,653

Schedule of preliminary estimate of the intangible assets

The following table summarizes the preliminary estimate of the intangible assets as of the acquisition date:

Estimated

Weighted

Average

Useful Lives

Estimated Fair

(in thousands, except for years)

    

in Years

    

Value

Developed technology

 

17

$

17,900

Customer relationships

 

1.5

 

510

Estimated fair value of acquired intangible assets

$

18,410

Schedule of pro forma financial results Additionally, the pro forma financial results do not include any anticipated synergies or other expected benefits from the iGenomX acquisition.

Year ended September 30,

(in thousands)

    

2021

    

2020

Revenues

$

132,599

$

90,650

Net loss attributable to common stockholders

 

(153,007)

 

(141,054)